# data[].attributes.body
The early 2000s witnessed a sharp rise in the misuse of prescription painkillers, particularly OxyContin. This phenomenon laid the groundwork for the widespread opioid crisis, as more individuals became dependent on these powerful medications.

# data[].attributes.body
In 2007, Purdue Pharma, the maker of OxyContin, was fined $634 million for misleading the public about the addiction risk of OxyContin. This marked a significant legal action highlighting the responsibility of pharmaceutical companies in the opioid crisis.

# data[].attributes.body
Around 2010, synthetic drugs such as synthetic cannabinoids (Spice) and synthetic cathinones (bath salts) began to gain popularity. These substances were easily accessible, often marketed as legal and safe alternatives, yet posed significant health risks.

# data[].attributes.headline
2012: National Drug Take Back Day Initiated

# data[].attributes.subject
2012: National Drug Take Back Day Initiated

# data[].attributes.body
To combat prescription drug abuse, the Drug Enforcement Administration (DEA) initiated National Drug Take Back Day in 2012. This event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs.

# data[].attributes.body
As prescription opioid controls tightened, many users turned to heroin, leading to a significant rise in heroin use and related deaths around 2014. This shift highlighted the evolving nature of substance abuse issues.

# data[].attributes.headline
2017: Opioid Crisis Declared a Public Health Emergency

# data[].attributes.subject
2017: Opioid Crisis Declared a Public Health Emergency

# data[].attributes.body
In 2017, the U.S. Department of Health and Human Services declared the opioid crisis a public health emergency. This declaration aimed to mobilize resources and increase efforts to combat the epidemic affecting millions of Americans.

# data[].attributes.body
Fentanyl, a powerful synthetic opioid, became a major concern by 2018 due to its potency and the rise in overdose deaths. Efforts to address fentanyl abuse included stronger regulation and increased public awareness campaigns.

# data[].attributes.body
The year 2019 saw an outbreak of lung illnesses linked to vaping, particularly with products containing THC. This public health crisis led to stricter regulations on vaping products and highlighted the dangers of this form of substance use.

# data[].attributes.headline
2020: Impact of COVID-19 on Substance Abuse

# data[].attributes.subject
2020: Impact of COVID-19 on Substance Abuse

# data[].attributes.body
The COVID-19 pandemic exacerbated substance abuse issues due to increased isolation, stress, and economic hardship. Overdose deaths surged during this period, underscoring the need for accessible treatment and support services.

# data[].attributes.body
As we look to the future, efforts to combat substance abuse continue with ongoing challenges. Education, prevention, and support services remain critical in addressing this complex issue and helping those affected by substance abuse.